AVROBIO Inc

NASDAQ: AVRO

AVRO Stock Chart and Intraday Price

AVRO Stock Data

Asset Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address ONE KENDALL SQUARE, BLDG. 300, SUITE 201, CAMBRIDGE, MA, US
Fiscal Year End December
Latest Quarter 2023-12-31
Market Cap 58.77M USD
Shares Outstanding 44,860,500
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases after a single dose worldwide. The company is headquartered in Cambridge, Massachusetts.

AVRO Articles

Tuesday Analyst Upgrades and Downgrades: Campbell Soup, Exact Sciences, Exelixis, Spirit Airlines, Sarepta, ZTO and More
Tuesday’s top analyst upgrades and downgrades included Campbell Soup, Exact Sciences, Exelixis, Pool, Spirit Airlines and ZTO Express.
Chris Lange
Published:

Thursday's Top Analyst Upgrades and Downgrades: Airbnb, CrowdStrike, DoorDash, Ford, Fortinet, Intuit, T-Mobile, Twilio, Zscaler and More
Thursday's top analyst upgrades and downgrades included Airbnb, CrowdStrike, DoorDash, Ford, Intuit, Lumber Liquidators, Occidental Petroleum, T-Mobile, Twilio, Uber and UBS.
Lee Jackson
Published:

Top Analyst Upgrades and Downgrades: Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber, Vonage, Yeti, Zillow and More
Friday's top analyst upgrades and downgrades included Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber Technologies, Vonage, Yeti and Zillow.
Jon C. Ogg
Published: